The generative rearchitecture of antibody engineering shifts empirical discovery into intentional design
Abstract Generative AI is reshaping antibody engineering by transitioning from empirical screening toward more specification-driven design, potentially expanding the accessible target landscape. While front-loading developability criteria helps streamline discovery timelines, data constraints still introduce risks of i...